|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Cost of goods sold | |||||
| Gross margin | |||||
| Operating expenses: | |||||
| Sales and marketing | |||||
| Product development | |||||
| General and administrative expenses | |||||
| Unrealized loss on digital assets | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net | |||||
| Loss on repayment of credit facility | |||||
| Loss on conversion and extinguishment of Convertible Notes | |||||
| Loss on repayment of May 2024 Notes | |||||
| Gain (loss) on change in fair value of financial liabilities | |||||
| Interest income | |||||
| Interest expense | |||||
| Issuance costs | |||||
| Loss on repayment of debt | |||||
| Gain (Loss) on derivative liabilities and warrant liabilities | |||||
| Total other expense | |||||
| Loss before provision for income taxes | |||||
| Provision for income taxes | |||||
| Loss from continuing operations before income tax | |||||
| Income tax benefit | |||||
| Loss from continuing operations | |||||
| Loss from discontinued operations | |||||
| Net loss | |||||
| Loss from continuing operations per common share - basic | |||||
| Loss from continuing operations per common share - diluted | |||||
| Loss from discontinued operations per common share - basic | |||||
| Loss from discontinued operations per common share - diluted | |||||
| Basic net loss per common share | |||||
| Diluted net loss per common share | |||||
| Weighted average common stock outstanding – basic | |||||
| Weighted average common stock outstanding – diluted | |||||
Loading...